Company Filing History:

12 out of 119

Ucb S.a.

Years Active: 1987-2002

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6436942 - Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine (2002-08-20),

2. 5792770 - Enantiomers of 1-�(4-chlorophenyl)phenylmethyl!-4-�(4-methylphenyl) (1998-08-11),

3. 5703082 - Enantiomers of 1-�(4-chlorophenyl)phenylmethyl!-�(4-methylphenyl)sulfonyl!p (1997-12-30),

4. 5478941 - Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) (1995-12-26),

5. 5447952 - Treatment of anxiety with the aid of (1995-09-05),

6. 5385927 - Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides and their (1995-01-31),

7. 5348956 - Substituted cyclopropylamino-1,3,5-triazines (1994-09-20),

8. 5258513 - Substituted cyclopropylamino-1,3,5-triazines (1993-11-02),

9. 5059528 - Expression of human proapolipoprotein A-I (1991-10-22),

10. 4956367 - 2-amino-4-morpholino-6-propyl-1,3,5-triazines (1990-09-11),

11. 4956363 - Treatment of cognitive and behavioral disorders associated with aging (1990-09-11),

12. 4943639 - (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide (1990-07-24),

13. 4923865 - Substituted 1-(1H-imidazol-4-yl)alkyl-benzamides as anti-ischemics and (1990-05-08),

14. 4837224 - (R)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions (1989-06-06),

15. 4837223 - (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions (1989-06-06),

Title: Jean Gobert: A Pioneering Inventor in Pharmaceutical Chemistry

Introduction

Jean Gobert, based in Brussels, Belgium, is a renowned inventor recognized for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 18 patents, Gobert has made substantial advancements in the field, particularly with his research focused on enantiomers, which are crucial in the development of optically active therapeutic compounds.

Latest Patents

Among Gobert's latest innovations are his patents pertaining to enantiomers of 1-[(4-chloro-phenyl)phenylmethyl]-4-[(4-methylphenyl)sulfony]piperazine. These patents detail the levorotatory and dextrorotatory enantiomers of this compound, outlining their preparation methods and applications. His work is pivotal for producing substantially optically pure enantiomers, which serve as valuable intermediate products necessary for creating optically active therapeutic compounds with a very high degree of optical purity.

Career Highlights

Throughout his career, Jean Gobert has been associated with prominent companies like UCB S.A. and UCB Société Anonyme, where he has contributed significantly to research and innovation in the pharmaceutical industry. His expertise in chemistry and patent strategies has enabled him to develop groundbreaking solutions that further the industry's capabilities.

Collaborations

In his endeavors, Gobert has collaborated with esteemed colleagues such as Eric Cossement and Guy Bodson. Together, they have advanced research projects and driven innovations that have impacted the pharmaceutical landscape considerably.

Conclusion

Jean Gobert stands out as a notable inventor whose work has profoundly influenced pharmaceutical chemistry. His extensive patent portfolio reflects his dedication and innovative approach in the pursuit of developing optically pure therapeutic compounds. As the industry continues to evolve, Gobert’s contributions remain a crucial foundation for ongoing research and development in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.